1 800 Flowers Com Inc: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 8, 2024 and accepted by EDGAR at May 8, 2024, 11:11 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $379.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-07-03 to 2024-03-31 | $1.47bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $240.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2023-07-03 to 2024-03-31 | $874.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-01-01 to 2024-03-31 | $138.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-07-03 to 2024-03-31 | $596.3m | us-gaap:GrossProfit |
| Operating income | 3 months2024-01-01 to 2024-03-31 | −$27.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-07-03 to 2024-03-31 | $25.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-01-01 to 2024-03-31 | −$8.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-07-03 to 2024-03-31 | $7.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | −$16.9m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-07-03 to 2024-03-31 | $14.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | −$0.26 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-07-03 to 2024-03-31 | $0.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | −$0.26 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-07-03 to 2024-03-31 | $0.23 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 64,489,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-07-03 to 2024-03-31 | 65,057,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-07-03 to 2024-03-31 | $100.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-07-03 to 2024-03-31 | $26.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2023-07-03 to 2024-03-31 | $9.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-03-31 | $184.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $396.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $1.04bn | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $210.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $554.7m | us-gaap:Liabilities |
| Long-term debt | At period end2024-03-31 | $179.4m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-03-31 | $10.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-03-31 | $485.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-24-015273. Last ingested by Listed: Nov 5, 2026, 11:53 ET. Listed shows no prices and gives no investment advice.